Jia Zhong Selected Research

Neoplasms (Cancer)

3/2024	A single-cell characterised signature integrating heterogeneity and microenvironment of lung adenocarcinoma for prognostic stratification.
3/2024	Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non-small cell lung cancer.
12/2023	Matrine Targets BTF3 to Inhibit the Growth of Canine Mammary Tumor Cells.
10/2023	Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity.
11/2022	Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors.
11/2022	A case of multiple primary lung adenocarcinoma with a CD74-NRG1 fusion protein and HER2 mutation benefit from combined target therapy.
10/2022	Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer.
10/2022	Kaempferol prevents angiogenesis of rat intestinal microvascular endothelial cells induced by LPS and TNF-α via inhibiting VEGF/Akt/p38 signaling pathways and maintaining gut-vascular barrier integrity.
1/2021	Plasma cytokines interleukin-18 and C-X-C motif chemokine ligand 10 are indicative of the anti-programmed cell death protein-1 treatment response in lung cancer patients.
8/2020	Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jia Zhong Research Topics

Disease

20	Neoplasms (Cancer) 03/2024 - 01/2013
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2014
12	Inflammation (Inflammations) 01/2022 - 07/2013
7	Lung Neoplasms (Lung Cancer) 10/2023 - 05/2014
6	Adenocarcinoma of Lung 01/2023 - 01/2016
3	Infections 07/2023 - 04/2023
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 04/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 11/2017
2	Hypoxia (Hypoxemia) 09/2023 - 10/2022
2	Osteoarthritis 01/2023 - 06/2020
2	Obesity 01/2022 - 01/2019
2	Disease Progression 01/2022 - 01/2015
2	Dysbiosis 01/2022 - 09/2020
2	Colitis 12/2021 - 09/2020
2	Hemophilia A (Haemophilia) 01/2021 - 09/2020
2	Hemorrhage 01/2021 - 09/2020
2	Asthma (Bronchial Asthma) 12/2020 - 11/2020
2	Cognitive Dysfunction 01/2018 - 11/2016
2	Chronic Disease (Chronic Diseases) 11/2017 - 02/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2017
2	Hypertension (High Blood Pressure) 01/2017 - 01/2017
1	Malignant Mesothelioma 04/2024
1	Breast Neoplasms (Breast Cancer) 12/2023
1	Atrophy 11/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2023
1	Huntington Disease (Huntington's Disease) 05/2023
1	Hematologic Neoplasms (Hematological Malignancy) 11/2022
1	Avulsion Fractures 01/2021
1	Endometriosis 12/2020
1	Osteoporotic Fractures 12/2020

Drug/Important Bio-Agent (IBA)

11	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2014
7	Tyrosine Kinase InhibitorsIBA 12/2017 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2013
5	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2009
4	MatrinesIBA 12/2023 - 04/2023
4	Particulate MatterIBA 11/2017 - 05/2014
3	FlavonoidsIBA 10/2022 - 06/2019
3	kaempferolIBA 10/2022 - 03/2019
3	CytokinesIBA 12/2021 - 01/2010
2	osimertinibIBA 01/2023 - 01/2021
2	ChemokinesIBA 11/2022 - 01/2021
2	LigandsIBA 11/2022 - 01/2021
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2021 - 09/2020
2	Pemetrexed (MTA)FDA Link 12/2020 - 06/2019
2	Budesonide (Pulmicort)FDA LinkGeneric 12/2020 - 11/2020
2	MicroRNAs (MicroRNA)IBA 06/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2014
2	Therapeutic UsesIBA 06/2019 - 01/2010
2	rheinIBA 06/2019 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2010
2	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 09/2017
2	Apolipoproteins E (ApoE)IBA 01/2018 - 11/2016
2	Blood Glucose (Blood Sugar)IBA 01/2017 - 11/2016
2	FluorineIBA 01/2015 - 01/2013
1	fms-Like Tyrosine Kinase 3IBA 01/2024
1	Biotin (Vitamin H)FDA Link 12/2023
1	Sincalide FDA Link 12/2023
1	polydatinIBA 11/2023
1	PPAR alphaIBA 09/2023
1	CarbohydratesIBA 09/2023
1	Lipase (Acid Lipase)FDA Link 09/2023
1	LipidsIBA 09/2023
1	laquinimodIBA 05/2023
1	EnzymesIBA 05/2023
1	Mixed Function Oxygenases (Monooxygenases)IBA 05/2023
1	diazonaphthalenedisulfonic acid (NDS)IBA 05/2023
1	KynurenineIBA 05/2023
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 05/2023
1	Antiviral Agents (Antivirals)IBA 04/2023
1	Circular RNAIBA 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2022
1	Histone Deacetylase InhibitorsIBA 11/2022
1	Neuregulin-1 (Neuregulin 1)IBA 11/2022
1	human ERBB2 proteinIBA 11/2022
1	AfatinibIBA 11/2022
1	Plant ExtractsIBA 10/2022
1	Vascular Endothelial Growth FactorsIBA 10/2022
1	TabletsIBA 01/2022
1	icotinibIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	apatinibIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 12/2020
1	PlatinumIBA 12/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 12/2020
1	Hormones (Hormone)IBA 12/2020
1	elagolixIBA 12/2020
1	montelukast (Singulair)FDA Link 12/2020
1	Dextrans (Dextran)FDA Link 09/2020

Therapy/Procedure

16	Therapeutics 04/2024 - 07/2013
6	Drug Therapy (Chemotherapy) 07/2020 - 11/2014
5	Immunotherapy 03/2024 - 01/2013
3	Radiotherapy 08/2020 - 01/2019
2	Aftercare (After-Treatment) 09/2017 - 01/2010
1	Salvage Therapy 04/2024
1	Neoadjuvant Therapy 01/2023
1	Sutures (Suture) 01/2021